Breaking News
Private credit markets have been in the headlines this week.
The bodily autonomy, privacy, due process, blue skies, nutrient dense food, freedom of speech...
Southwest Airlines Ends Flights To Chicago O'Hare And Washington Dulles, A Boost For United
When the government says 'we are all in the same boat
Top Tech News
Musk Whips Out 'Macrohard' In Disruptive Tesla-xAI Bid To Shaft Software Companies
This Bonkers Folding X-Plane Is One Step Closer to Hitting the Skies
Smart 2-in-1 digital microscope goes desktop or handheld as needed
Human Brain Cells Merge With Silica To Play DOOM
Will Yann LeCun Provide The Next Breakthrough In AI?
Human Brain Cells Merge With Silica To Play DOOM
Solar And Storage Could Reshape Rural Electricity Markets
With World Seemingly At War, DARPA Finds Time To Unveil The X-76
Renewable Water From Air.
The world's first diesel plug-in hybrid pickup truck is here
FDA Gives Emergency Authorization of Hydroxychloroquine Use
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the "off-label" drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.